An independent relationship between increased circulating levels of FGF-23, incident heart failure and cardiovascular mortality has previously been described in large community-based studies [5, 6] and, recently, a similar relationship was confirmed in a larger cohort of patients with type 2 diabetes [9]. The gene discussed is FGF23; the disease is heart failure.